Hanmi Science
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more
Hanmi Science (008930) - Total Assets
Latest total assets as of September 2025: ₩1.45 Trillion KRW
Based on the latest financial reports, Hanmi Science (008930) holds total assets worth ₩1.45 Trillion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hanmi Science - Total Assets Trend (2000–2024)
This chart illustrates how Hanmi Science’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hanmi Science - Asset Composition Analysis
Current Asset Composition (December 2024)
Hanmi Science's total assets of ₩1.45 Trillion consist of 24.3% current assets and 75.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 6.3% |
| Accounts Receivable | ₩102.15 Billion | 7.6% |
| Inventory | ₩108.73 Billion | 8.1% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩54.54 Billion | 4.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Hanmi Science's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hanmi Science's current assets represent 24.3% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 6.3% of total assets in 2024, down from 9.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 8.1% of total assets.
Hanmi Science Competitors by Total Assets
Key competitors of Hanmi Science based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
|
China Meheco Co Ltd
SHG:600056
|
China | CN¥36.99 Billion |
Hanmi Science - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Hanmi Science generates 0.95x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Hanmi Science generates $ 4.40 in net profit.
Hanmi Science - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.74 | 0.67 | 0.98 |
| Quick Ratio | 0.50 | 0.42 | 0.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩-125.20 Billion | ₩ -139.95 Billion | ₩ -4.39 Billion |
Hanmi Science - Advanced Valuation Insights
This section examines the relationship between Hanmi Science's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.88 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 10.0% |
| Total Assets | ₩1.35 Trillion |
| Market Capitalization | $673.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hanmi Science's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hanmi Science's assets grew by 10.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hanmi Science (2000–2024)
The table below shows the annual total assets of Hanmi Science from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩1.35 Trillion | +10.02% |
| 2023-12-31 | ₩1.23 Trillion | +10.50% |
| 2022-12-31 | ₩1.11 Trillion | +16.82% |
| 2021-12-31 | ₩949.89 Billion | +2.89% |
| 2020-12-31 | ₩923.22 Billion | +1.36% |
| 2019-12-31 | ₩910.83 Billion | -0.62% |
| 2018-12-31 | ₩916.55 Billion | -2.37% |
| 2017-12-31 | ₩938.78 Billion | -3.14% |
| 2016-12-31 | ₩969.25 Billion | +3.99% |
| 2015-12-31 | ₩932.02 Billion | +25.48% |
| 2014-12-31 | ₩742.80 Billion | +28.11% |
| 2013-12-31 | ₩579.82 Billion | +19.45% |
| 2012-12-31 | ₩485.39 Billion | +19.51% |
| 2011-12-31 | ₩406.16 Billion | -60.56% |
| 2010-12-31 | ₩1.03 Trillion | +15.00% |
| 2009-12-31 | ₩895.44 Billion | +6.80% |
| 2008-12-31 | ₩838.43 Billion | +21.48% |
| 2007-12-31 | ₩690.20 Billion | +31.33% |
| 2006-12-31 | ₩525.55 Billion | +28.52% |
| 2005-12-31 | ₩408.94 Billion | +12.08% |
| 2004-12-31 | ₩364.87 Billion | +11.30% |
| 2003-12-31 | ₩327.82 Billion | +7.30% |
| 2002-12-31 | ₩305.50 Billion | +3.27% |
| 2001-12-31 | ₩295.82 Billion | +19.68% |
| 2000-12-31 | ₩247.17 Billion | -- |